| Literature DB >> 17205485 |
Julie Fotheringham1, Nahid Akhyani, Alexander Vortmeyer, Donatella Donati, Elizabeth Williams, Unsong Oh, Michael Bishop, John Barrett, Juan Gea-Banacloche, Steven Jacobson.
Abstract
One-half of bone-marrow transplant (BMT) and stem-cell transplant recipients have reactivation of latent human herpesvirus (HHV)-6 2-4 weeks after transplant. Although the detection of viral DNA, RNA, and antigen in brain material confirmed active HHV-6 variant B infection, peak viral loads in cerebrospinal fluid (CSF) and serum occurred 2-4 weeks before death and decreased to low levels before or at autopsy. All autopsy samples consistently demonstrated HHV-6 active infection in the hippocampus. Astrocytic cells positive for viral antigen provided support for an HHV-6-specific tropism for hippocampal astrocytes. HHV-6 DNA in CSF and serum may not reflect the level of active viral infection in the brain after BMT.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17205485 DOI: 10.1086/510757
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226